Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin.

Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ.

Nature. 1995 Oct 19;377(6550):649-52.

PMID:
7566180
2.

Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.

Ohndorf UM, Rould MA, He Q, Pabo CO, Lippard SJ.

Nature. 1999 Jun 17;399(6737):708-12.

PMID:
10385126
4.
5.

Repair of cisplatin--DNA adducts by the mammalian excision nuclease.

Zamble DB, Mu D, Reardon JT, Sancar A, Lippard SJ.

Biochemistry. 1996 Aug 6;35(31):10004-13.

PMID:
8756462
6.

2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex.

Spingler B, Whittington DA, Lippard SJ.

Inorg Chem. 2001 Oct 22;40(22):5596-602. Erratum in: Inorg Chem. 2003 Jan 27;42(2):650.

PMID:
11599959
7.

Intercalating residues determine the mode of HMG1 domains A and B binding to cisplatin-modified DNA.

He Q, Ohndorf UM, Lippard SJ.

Biochemistry. 2000 Nov 28;39(47):14426-35.

PMID:
11087395
8.
9.

DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.

Kasparkova J, Novakova O, Farrell N, Brabec V.

Biochemistry. 2003 Jan 28;42(3):792-800.

PMID:
12534292
10.

HMG domain proteins induce sharp bends in cisplatin-modified DNA.

Chow CS, Whitehead JP, Lippard SJ.

Biochemistry. 1994 Dec 20;33(50):15124-30.

PMID:
7999772
11.

Stopped-flow fluorescence studies of HMG-domain protein binding to cisplatin-modified DNA.

Jamieson ER, Lippard SJ.

Biochemistry. 2000 Jul 25;39(29):8426-38.

PMID:
10913248
12.

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.

Huang JC, Zamble DB, Reardon JT, Lippard SJ, Sancar A.

Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10394-8.

13.

HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts.

Cohen SM, Mikata Y, He Q, Lippard SJ.

Biochemistry. 2000 Sep 26;39(38):11771-6.

PMID:
10995245
14.

Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin.

Donahue BA, Augot M, Bellon SF, Treiber DK, Toney JH, Lippard SJ, Essigmann JM.

Biochemistry. 1990 Jun 19;29(24):5872-80.

PMID:
2383564
15.
16.
17.
18.

Binding of Ixr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo.

McA'Nulty MM, Whitehead JP, Lippard SJ.

Biochemistry. 1996 May 14;35(19):6089-99.

PMID:
8634251
19.

HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts.

Hoffmann JS, Locker D, Villani G, Leng M.

J Mol Biol. 1997 Jul 25;270(4):539-43.

PMID:
9245584
20.

DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNA.

Dunham SU, Lippard SJ.

Biochemistry. 1997 Sep 23;36(38):11428-36. Erratum in: Biochemistry 1997 Nov 11;36(45):13972.

PMID:
9298962

Supplemental Content

Support Center